155 related articles for article (PubMed ID: 16094129)
1. Molecular prognosticators and genomic instability in papillary thyroid cancer.
Rigual NR; Anderson GR; Loree TR; Wiseman S; Alrawi S; Stoler DL
Laryngoscope; 2005 Aug; 115(8):1479-85. PubMed ID: 16094129
[TBL] [Abstract][Full Text] [Related]
2. Papillary thyroid cancer: high inter-(simple sequence repeat) genomic instability in a typically indolent cancer.
Wiseman SM; Loree TR; Rigual NR; Hicks WL; Winston JS; Swede H; Bartos JD; Anderson GR; Stoler DL
Head Neck; 2003 Oct; 25(10):825-32. PubMed ID: 12966506
[TBL] [Abstract][Full Text] [Related]
3. The null genotype of glutathione s-transferase M1 and T1 locus increases the risk for thyroid cancer.
Morari EC; Leite JL; Granja F; da Assumpção LV; Ward LS
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1485-8. PubMed ID: 12433731
[TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphism at GSTM1 and GSTT1 gene loci and susceptibility to oral cancer.
Sharma A; Mishra A; Das BC; Sardana S; Sharma JK
Neoplasma; 2006; 53(4):309-15. PubMed ID: 16830058
[TBL] [Abstract][Full Text] [Related]
5. Glutathione S-transferase M1 gene null genotype and gastric cancer risk in Taiwan.
Lai KC; Chen WC; Tsai FJ; Li SY; Chou MC; Jeng LB
Hepatogastroenterology; 2005; 52(66):1916-9. PubMed ID: 16334806
[TBL] [Abstract][Full Text] [Related]
6. Association of GST genotypes with age of onset and lymph node metastasis in oral squamous cell carcinoma.
Liu CJ; Chang CS; Lui MT; Dang CW; Shih YH; Chang KW
J Oral Pathol Med; 2005 Sep; 34(8):473-7. PubMed ID: 16091114
[TBL] [Abstract][Full Text] [Related]
7. Genotypes of TNF-alpha, VEGF, hOGG1, GSTM1, and GSTT1: useful determinants for clinical outcome of bladder cancer.
Kim EJ; Jeong P; Quan C; Kim J; Bae SC; Yoon SJ; Kang JW; Lee SC; Jun Wee J; Kim WJ
Urology; 2005 Jan; 65(1):70-5. PubMed ID: 15667866
[TBL] [Abstract][Full Text] [Related]
8. Association of genetic polymorphisms in glutathione S-transferases and susceptibility to head and neck cancer.
Singh M; Shah PP; Singh AP; Ruwali M; Mathur N; Pant MC; Parmar D
Mutat Res; 2008 Feb; 638(1-2):184-94. PubMed ID: 18035380
[TBL] [Abstract][Full Text] [Related]
9. FHIT and TSG101 in thyroid tumours: aberrant transcripts reflect rare abnormal RNA processing events of uncertain pathogenetic or clinical significance.
McIver B; Grebe SK; Wang L; Hay ID; Yokomizo A; Liu W; Goellner JR; Grant CS; Smith DI; Eberhardt NL
Clin Endocrinol (Oxf); 2000 Jun; 52(6):749-57. PubMed ID: 10848880
[TBL] [Abstract][Full Text] [Related]
10. Interaction of glutathione S-transferase M1 and T1 genotypes and malignant melanoma.
Kanetsky PA; Holmes R; Walker A; Najarian D; Swoyer J; Guerry D; Halpern A; Rebbeck TR
Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):509-13. PubMed ID: 11352862
[TBL] [Abstract][Full Text] [Related]
11. Smoking and susceptibility to thyroid cancer: an inverse association with CYP1A1 allelic variants.
Bufalo NE; Leite JL; Guilhen AC; Morari EC; Granja F; Assumpcao LV; Ward LS
Endocr Relat Cancer; 2006 Dec; 13(4):1185-93. PubMed ID: 17158763
[TBL] [Abstract][Full Text] [Related]
12. Glutathione S-transferase M1, T1 and P1 polymorphisms: susceptibility and outcome in lung cancer patients.
Sreeja L; Syamala V; Hariharan S; Syamala VS; Raveendran PB; Sivanandan CD; Madhavan J; Ankathil R
J Exp Ther Oncol; 2008; 7(1):73-85. PubMed ID: 18472644
[TBL] [Abstract][Full Text] [Related]
13. Relation of glutathione S-transferase genotypes (GSTM1 and GSTT1) to laryngeal squamous cell carcinoma risk.
Acar H; Ozturk K; Muslumanoglu MH; Yildirim MS; Cora T; Cilingir O; Ozer B
Cancer Genet Cytogenet; 2006 Sep; 169(2):89-93. PubMed ID: 16938565
[TBL] [Abstract][Full Text] [Related]
14. Glutathione S-transferase-mu (GSTM1) and -theta (GSTT1) genotypes in the etiology of prostate cancer.
Rebbeck TR; Walker AH; Jaffe JM; White DL; Wein AJ; Malkowicz SB
Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):283-7. PubMed ID: 10207629
[TBL] [Abstract][Full Text] [Related]
15. Glutathione S-transferase polymorphisms and risk of differentiated thyroid carcinomas: a case-control analysis.
Ho T; Zhao C; Zheng R; Liu Z; Wei Q; Sturgis EM
Arch Otolaryngol Head Neck Surg; 2006 Jul; 132(7):756-61. PubMed ID: 16847185
[TBL] [Abstract][Full Text] [Related]
16. GST profiling may be useful in the screening for thyroid nodule malignancy.
Granja F; Morari J; Morari EC; Correa LA; Assumpção LV; Ward LS
Cancer Lett; 2004 Jun; 209(2):129-37. PubMed ID: 15159014
[TBL] [Abstract][Full Text] [Related]
17. Increased frequencies of glutathione-S-transferase (GSTM1 and GSTT1) null genotypes in Indian patients with chronic myeloid leukemia.
Bajpai P; Tripathi AK; Agrawal D
Leuk Res; 2007 Oct; 31(10):1359-63. PubMed ID: 17420047
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphisms of glutathione-S-transferase genes (GSTM1, GSTT1 and GSTP1) and upper aerodigestive tract cancer risk among smokers, tobacco chewers and alcoholics in an Indian population.
Soya SS; Vinod T; Reddy KS; Gopalakrishnan S; Adithan C
Eur J Cancer; 2007 Dec; 43(18):2698-706. PubMed ID: 17707637
[TBL] [Abstract][Full Text] [Related]
19. Detection and relevance of germline genetic polymorphisms in glutathione S-transferases (GSTs) in breast cancer patients from northern Indian population.
Saxena A; Dhillon VS; Raish M; Asim M; Rehman S; Shukla NK; Deo SV; Ara A; Husain SA
Breast Cancer Res Treat; 2009 Jun; 115(3):537-43. PubMed ID: 18574688
[TBL] [Abstract][Full Text] [Related]
20. Prognostic variables and calcitonin in medullary thyroid cancer.
Clark JR; Fridman TR; Odell MJ; Brierley J; Walfish PG; Freeman JL
Laryngoscope; 2005 Aug; 115(8):1445-50. PubMed ID: 16094121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
